Phase I trial of HX 100 in healthy volunteers

Trial Profile

Phase I trial of HX 100 in healthy volunteers

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Jan 2016

At a glance

  • Drugs HX 100 (Primary)
  • Indications Allergic asthma; Diabetic neuropathies; Neuropathic pain
  • Focus Adverse reactions
  • Sponsors Hydra Biosciences
  • Most Recent Events

    • 16 Apr 2015 New trial record
    • 14 Apr 2015 Health Canada has approved Hydra Biosciences' Clinical Trial Application to begin this trial, according to a media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top